Allowed Publications
Slot System
Featured Buckets
Featured Buckets Admin

Natural vs. Artificial Colloids

Article Type
Changed
Display Headline
Natural vs. Artificial Colloids

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(8)
Publications
Page Number
45
Legacy Keywords
adverse drug effects and interactions, surgery, colloids, natural, artificial, albumin, hydroxyethyl starch, dextran, gelatinadverse drug effects and interactions, surgery, colloids, natural, artificial, albumin, hydroxyethyl starch, dextran, gelatin
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(8)
Issue
Federal Practitioner - 21(8)
Page Number
45
Page Number
45
Publications
Publications
Article Type
Display Headline
Natural vs. Artificial Colloids
Display Headline
Natural vs. Artificial Colloids
Legacy Keywords
adverse drug effects and interactions, surgery, colloids, natural, artificial, albumin, hydroxyethyl starch, dextran, gelatinadverse drug effects and interactions, surgery, colloids, natural, artificial, albumin, hydroxyethyl starch, dextran, gelatin
Legacy Keywords
adverse drug effects and interactions, surgery, colloids, natural, artificial, albumin, hydroxyethyl starch, dextran, gelatinadverse drug effects and interactions, surgery, colloids, natural, artificial, albumin, hydroxyethyl starch, dextran, gelatin
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Simvastatin for MS?

Article Type
Changed
Display Headline
Simvastatin for MS?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(8)
Publications
Topics
Page Number
45
Legacy Keywords
neurology, simvastatin, MS, multiple sclerosisneurology, simvastatin, MS, multiple sclerosis
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(8)
Issue
Federal Practitioner - 21(8)
Page Number
45
Page Number
45
Publications
Publications
Topics
Article Type
Display Headline
Simvastatin for MS?
Display Headline
Simvastatin for MS?
Legacy Keywords
neurology, simvastatin, MS, multiple sclerosisneurology, simvastatin, MS, multiple sclerosis
Legacy Keywords
neurology, simvastatin, MS, multiple sclerosisneurology, simvastatin, MS, multiple sclerosis
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

New Answer to Acute Hypomobility in Parkinson's Disease

Article Type
Changed
Display Headline
New Answer to Acute Hypomobility in Parkinson's Disease

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(7)
Publications
Topics
Page Number
55
Legacy Keywords
neurology, acute hypomobility, parkinson's disease, apomorphineneurology, acute hypomobility, parkinson's disease, apomorphine
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(7)
Issue
Federal Practitioner - 21(7)
Page Number
55
Page Number
55
Publications
Publications
Topics
Article Type
Display Headline
New Answer to Acute Hypomobility in Parkinson's Disease
Display Headline
New Answer to Acute Hypomobility in Parkinson's Disease
Legacy Keywords
neurology, acute hypomobility, parkinson's disease, apomorphineneurology, acute hypomobility, parkinson's disease, apomorphine
Legacy Keywords
neurology, acute hypomobility, parkinson's disease, apomorphineneurology, acute hypomobility, parkinson's disease, apomorphine
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

More Beta-Blockers, Please

Article Type
Changed
Display Headline
More Beta-Blockers, Please

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(7)
Publications
Topics
Page Number
55
Legacy Keywords
cardiovascular disease, surgery, beta-blockerscardiovascular disease, surgery, beta-blockers
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(7)
Issue
Federal Practitioner - 21(7)
Page Number
55
Page Number
55
Publications
Publications
Topics
Article Type
Display Headline
More Beta-Blockers, Please
Display Headline
More Beta-Blockers, Please
Legacy Keywords
cardiovascular disease, surgery, beta-blockerscardiovascular disease, surgery, beta-blockers
Legacy Keywords
cardiovascular disease, surgery, beta-blockerscardiovascular disease, surgery, beta-blockers
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Carnitines vs. Testosterone for "Male Climacteric"

Article Type
Changed
Display Headline
Carnitines vs. Testosterone for "Male Climacteric"

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(7)
Publications
Page Number
50
Legacy Keywords
urology, carnitines, testosterone, climactericurology, carnitines, testosterone, climacteric
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(7)
Issue
Federal Practitioner - 21(7)
Page Number
50
Page Number
50
Publications
Publications
Article Type
Display Headline
Carnitines vs. Testosterone for "Male Climacteric"
Display Headline
Carnitines vs. Testosterone for "Male Climacteric"
Legacy Keywords
urology, carnitines, testosterone, climactericurology, carnitines, testosterone, climacteric
Legacy Keywords
urology, carnitines, testosterone, climactericurology, carnitines, testosterone, climacteric
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Zoledronic Acid and Interferon Alfa: A Call for Caution

Article Type
Changed
Display Headline
Zoledronic Acid and Interferon Alfa: A Call for Caution

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(7)
Publications
Page Number
49
Legacy Keywords
adverse drug effects and interactions, zoledronic acid, interferon alfaadverse drug effects and interactions, zoledronic acid, interferon alfa
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(7)
Issue
Federal Practitioner - 21(7)
Page Number
49
Page Number
49
Publications
Publications
Article Type
Display Headline
Zoledronic Acid and Interferon Alfa: A Call for Caution
Display Headline
Zoledronic Acid and Interferon Alfa: A Call for Caution
Legacy Keywords
adverse drug effects and interactions, zoledronic acid, interferon alfaadverse drug effects and interactions, zoledronic acid, interferon alfa
Legacy Keywords
adverse drug effects and interactions, zoledronic acid, interferon alfaadverse drug effects and interactions, zoledronic acid, interferon alfa
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Better Odds with Intensive Statins?

Article Type
Changed
Display Headline
Better Odds with Intensive Statins?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(7)
Publications
Topics
Page Number
49
Legacy Keywords
cardiovascular disease, statins, pravastatin, atorvastatin, acute coronary syndromecardiovascular disease, statins, pravastatin, atorvastatin, acute coronary syndrome
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(7)
Issue
Federal Practitioner - 21(7)
Page Number
49
Page Number
49
Publications
Publications
Topics
Article Type
Display Headline
Better Odds with Intensive Statins?
Display Headline
Better Odds with Intensive Statins?
Legacy Keywords
cardiovascular disease, statins, pravastatin, atorvastatin, acute coronary syndromecardiovascular disease, statins, pravastatin, atorvastatin, acute coronary syndrome
Legacy Keywords
cardiovascular disease, statins, pravastatin, atorvastatin, acute coronary syndromecardiovascular disease, statins, pravastatin, atorvastatin, acute coronary syndrome
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Rasagiline: The Sooner, the Better

Article Type
Changed
Display Headline
Rasagiline: The Sooner, the Better

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(6)
Publications
Page Number
34
Legacy Keywords
neurology, rasagiline, parkinson's disease, PDneurology, rasagiline, parkinson's disease, PD
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(6)
Issue
Federal Practitioner - 21(6)
Page Number
34
Page Number
34
Publications
Publications
Article Type
Display Headline
Rasagiline: The Sooner, the Better
Display Headline
Rasagiline: The Sooner, the Better
Legacy Keywords
neurology, rasagiline, parkinson's disease, PDneurology, rasagiline, parkinson's disease, PD
Legacy Keywords
neurology, rasagiline, parkinson's disease, PDneurology, rasagiline, parkinson's disease, PD
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

TB Treatment and Electrolyte Disturbance

Article Type
Changed
Display Headline
TB Treatment and Electrolyte Disturbance

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(6)
Publications
Topics
Page Number
34
Legacy Keywords
adverse drug effects and interactions, infectious diseases, respiratory diseases, TB, tuberculosis, electrolyteadverse drug effects and interactions, infectious diseases, respiratory diseases, TB, tuberculosis, electrolyte
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(6)
Issue
Federal Practitioner - 21(6)
Page Number
34
Page Number
34
Publications
Publications
Topics
Article Type
Display Headline
TB Treatment and Electrolyte Disturbance
Display Headline
TB Treatment and Electrolyte Disturbance
Legacy Keywords
adverse drug effects and interactions, infectious diseases, respiratory diseases, TB, tuberculosis, electrolyteadverse drug effects and interactions, infectious diseases, respiratory diseases, TB, tuberculosis, electrolyte
Legacy Keywords
adverse drug effects and interactions, infectious diseases, respiratory diseases, TB, tuberculosis, electrolyteadverse drug effects and interactions, infectious diseases, respiratory diseases, TB, tuberculosis, electrolyte
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Peginterferon Alfa-2a Plus Ribavirin for HCV: How Long and How Much?

Article Type
Changed
Display Headline
Peginterferon Alfa-2a Plus Ribavirin for HCV: How Long and How Much?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(6)
Publications
Topics
Page Number
33
Legacy Keywords
hepatology, peginterferon alfa-2a, ribavirin, HCV, hepatitis Chepatology, peginterferon alfa-2a, ribavirin, HCV, hepatitis C
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(6)
Issue
Federal Practitioner - 21(6)
Page Number
33
Page Number
33
Publications
Publications
Topics
Article Type
Display Headline
Peginterferon Alfa-2a Plus Ribavirin for HCV: How Long and How Much?
Display Headline
Peginterferon Alfa-2a Plus Ribavirin for HCV: How Long and How Much?
Legacy Keywords
hepatology, peginterferon alfa-2a, ribavirin, HCV, hepatitis Chepatology, peginterferon alfa-2a, ribavirin, HCV, hepatitis C
Legacy Keywords
hepatology, peginterferon alfa-2a, ribavirin, HCV, hepatitis Chepatology, peginterferon alfa-2a, ribavirin, HCV, hepatitis C
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media